Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

Sickness and Society: The Future of Infectious Disease in the Workplace

Strategies for a safer, healthier workface amid COVID-19 and beyond.

State of the States

Sandy Shtab, Healthesystems AVP of Advocacy and Compliance, comments on regulatory activity across the country.

Stepping Up to Take on Pandemic Ripple Effects

A message from the Chief Executive Officer

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

FDA Considers Policy Changes for GLP-1 Compounds

Tirzepatide was no longer considered in shortage, removing compounding privileges, until litigation remanded the decision.
Oct 2024

Expert Q&A: Cybersecurity Tactics in Workers’ Compensation

Healthes’ AVP of Information Security, Tony Brown, discusses how cyber threats affect workers’ comp organizations.
Oct 2024

New Opioid Prescribing and Abuse Data

NCCI hosted a recent webinar on opioid utilization, while Fair Health published a new Opioid Tracker tool to monitor state opioid data.
Oct 2024

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

FDA Addresses Manufacturing Disruptions

Will disruptions in manufacturing result in drug shortages?
Mar 2020

NSAID Use and COVID-19

FDA investigates claims that NSAID use could aggravate COVID-19 symptoms.
Mar 2020

COVID-19 and Clinical Trials

COVID-19 drug trials are underway, but the pandemic is disrupting clinical testing.
Mar 2020
1 15 16 17 18 19 26

Whitepapers

lockmap-markermagnifiercrossmenucross-circle